Senior CRA, Phase I Oncology – Trial Lead

ICON Clinical Research; Sydney; Presencial; AUD 120.000 - 170.000; Jornada completa

Descripción de la vacante

ICON Plc is seeking a Senior Clinical Research Associate (Phase I) to join our Sydney team. You will oversee monitoring activities across sites in NSW/VIC, ensuring studies comply with protocol, GCP and regulatory standards, and that data collection is accurate and timely.

You will lead site visits, resolve issues, train site staff, and collaborate with cross-functional teams to drive quality and trial integrity while travelling up to 60% of the time.

Formación

• Bachelor's degree in a relevant scientific discipline or healthcare-related field.
• Extensive experience as a Clinical Research Associate with regulatory knowledge.
• Proven ability to manage multiple sites and projects simultaneously.
• Expertise in monitoring practices, data integrity, and site management.
• Excellent communication and stakeholder management skills.
• Willingness to travel approximately 60%.

Responsabilidades

• Lead clinical trial monitoring tasks with focus on quality and continuous improvement.
• Monitor sites to ensure adherence to protocols, GCP, and regulatory requirements.
• Conduct site visits to assess performance and resolve issues.
• Collaborate with cross-functional teams for timely data collection and reporting.
• Provide training and guidance to site staff and other CRAs.

Conocimientos

Site monitoring

Regulatory compliance

Data integrity

Stakeholder management

Communication

Educación

Bachelor's degree in a relevant scientific discipline

Herramientas

Clinical trial software

EDC systems

Descripción del empleo

ICON Plc is seeking a Senior Clinical Research Associate (Phase I) to join our Sydney team. You will oversee monitoring activities across sites in NSW/VIC, ensuring studies comply with protocol, GCP and regulatory standards, and that data collection is accurate and timely.

You will lead site visits, resolve issues, train site staff, and collaborate with cross-functional teams to drive quality and trial integrity while travelling up to 60% of the time.